Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Roles and mechanisms of tumour-infiltrating B cells in human cancer: a new force in immunotherapy
Enkui Zhang, Chengsheng Ding, Shuchun Li, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

Co-inhibition of TIGIT and PD-1/PD-L1 in Cancer Immunotherapy: Mechanisms and Clinical Trials
Xianjing Chu, Wentao Tian, Ziqi Wang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 92
Investigating the Dynamic Interplay Between Cellular Immunity and Tumor Cells in the Fight Against Cancer: An Updated Comprehensive Review
Seyed Ali Aghapour, Mehdi Torabizadeh, Seyed Sobhan Bahreiny, et al.
Iranian Journal of Blood and Cancer (2024) Vol. 16, Iss. 2, pp. 84-101
Closed Access | Times Cited: 34
Tumor-infiltrating plasma cells are a prognostic factor in penile squamous cell carcinoma
Peter Stenzel, Ann Thomas, Mario Schindeldecker, et al.
Virchows Archiv (2025)
Open Access | Times Cited: 2
The therapeutic potential of PD-1/PD-L1 pathway on immune-related diseases: Based on the innate and adaptive immune components
Peng Zhang, Yuting Wang, Qianru Miao, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115569-115569
Open Access | Times Cited: 24
The phosphatidylserine targeting antibody bavituximab plus pembrolizumab in unresectable hepatocellular carcinoma: a phase 2 trial
David Hsiehchen, Muhammad S. Beg, Radhika Kainthla, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 14
Obesity, Dietary Fats, and Gastrointestinal Cancer Risk-Potential Mechanisms Relating to Lipid Metabolism and Inflammation
Kathleen A. J. Mitchelson, Fiona O’Connell, Jacintha O’Sullivan, et al.
Metabolites (2024) Vol. 14, Iss. 1, pp. 42-42
Open Access | Times Cited: 11
Immune Cell Interactions and Immune Checkpoints in the Tumor Microenvironment of Gastric Cancer
Andreea-Raluca Cozac-Szőke, Dan Alexandru Cozac, Anca Negovan, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1156-1156
Open Access | Times Cited: 1
Flow cytometry immune profiling of recurrent and newly diagnosed growth hormone secreting pituitary neuroendocrine tumors: comparison of two clinical cases
Daria Lisina, Valeria Mazeeva, Е. Н. Захарова, et al.
BMC Endocrine Disorders (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
New insights into the role of the oral leukoplakia microenvironment in malignant transformation
Wilfredo Alejandro González‐Arriagada, Gisela Canedo-Marroquín, Daniela Adorno-Farías, et al.
Frontiers in Oral Health (2024) Vol. 5
Open Access | Times Cited: 8
Biophysical and biochemical aspects of immune cell–tumor microenvironment interactions
Shoham Benmelech, Thien Le, M. McKay, et al.
APL Bioengineering (2024) Vol. 8, Iss. 2
Open Access | Times Cited: 7
Re-analysis of single cell and spatial transcriptomics data reveals B cell landscape in gastric cancer microenvironment and its potential crosstalk with tumor cells for clinical prognosis
Xing Cai, Jinru Yang, Yusheng Guo, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Bioinformatic characterization of STING expression in hematological malignancies reveals association with prognosis and anti-tumor immunity
Xiang‐mei Wen, Zi‐jun Xu, Ji‐chun Ma, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Nanozyme-Based Strategies in Cancer Immunotherapy: Overcoming Resistance to Enhance Therapeutic Efficacy
Guangjian Hou, Yukun Xu, Chunhua Wang, et al.
Aging and Disease (2025)
Open Access
Spatial organization of B lymphocytes and prognosis prediction in patients with gastric cancer
Ryan Yong Kiat Tay, Manavi Sachdeva, Haoran Ma, et al.
Gastric Cancer (2025)
Open Access
B cell immunometabolism in health and disease
Eleonora Martinis, Silvia Tonon, Alessandra Colamatteo, et al.
Nature Immunology (2025)
Closed Access
Construction of hot tumor classification models in gastrointestinal cancers
Chien-Jung Huang, Guan‐Ting Liu, Yi-Chen Yeh, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Transcriptome-Wide Analysis and Experimental Validation from FFPE Tissue Identifies Stage-Specific Gene Expression Profiles Differentiating Adenoma, Carcinoma In-Situ and Adenocarcinoma in Colorectal Cancer Progression
Faisal Alhosani, Reem Sami Alhamidi, Burcu Yener Ilce, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 9, pp. 4194-4194
Open Access
Selenium Nanoparticles Synergize with a KRAS Nanovaccine against Breast Cancer
Cláudio Ferro, Ana I. Matos, Luigia Serpico, et al.
Advanced Healthcare Materials (2024)
Open Access | Times Cited: 3
Extracellular Vesicle-Based Strategies for Tumor Immunotherapy
Luksika Jiramonai, Xing-Jie Liang, Mengliang Zhu
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 257-257
Open Access
The evolving role of B cells in malignancies
Samik Bindu, Roshni Bibi, Roshini Pradeep, et al.
Human Immunology (2025) Vol. 86, Iss. 3, pp. 111301-111301
Closed Access
Age-related divergence of circulating immune responses in patients with solid tumors treated with immune checkpoint inhibitors
Chester Kao, Soren Charmsaz, Hua‐Ling Tsai, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
The pathogenesis of neurological immune-related adverse events following immune checkpoint inhibitor therapy
Magdalena Lerch, Sudarshini Ramanathan
Seminars in Immunology (2025) Vol. 78, pp. 101956-101956
Open Access
Durvalumab-associated Limbal Stem Cell Deficiency and Secondary Corneal Perforation
Nahrain Putris Schumaier, David G. Heidemann, Chirag Gupta
American Journal of Ophthalmology Case Reports (2024) Vol. 35, pp. 102074-102074
Open Access | Times Cited: 3
Expression, regulation, and function of PD-L1 on non-tumor cells in the tumor microenvironment
Lingrong Hu, Chengliang Sun, Kai Yuan, et al.
Drug Discovery Today (2024), pp. 104181-104181
Closed Access | Times Cited: 2
Integrative analysis of pan-cancer single-cell data reveals a tumor ecosystem subtype predicting immunotherapy response
Shengjie Zeng, Liu-xun Chen, Jinyu Tian, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top